Induction of cardiac beta-adrenergic receptor kinase 1 in rat heart failure caused by coronary ligation.
Beta-adrenergic receptor kinase 1 (beta ARK1) participates in the desensitization of beta-adrenergic receptors by uncoupling the signal transduction. The present study was designed to examine whether neurohumoral increase is crucial for the activation of beta ARK1 in heart failure. Four weeks after the ligation of rat coronary artery, LV dP/d t max was reduced, cardiac response to isoproterenol was impaired, and ratio of right ventricular weight to body weight, an index of cardiac hypertrophy, was increased. At the same time, beta ARK1 expression and activity were augmented in the hypertrophied hearts. In addition, plasma norepinephrine content was enhanced in accordance with cardiac hypertrophy, cardiac beta ARK1 expression, LV dP/d t max, and LVEDP. These results of the present study suggest that beta ARK1 is augmented in concert with circulating norepinephrine level and that beta ARK1 may account for, at least in part, the cardiac dysfunction in rat with myocardial infarction.
Ishigai
Y
Y
New Product Research Laboratories II, Tokyo R&D Center, Daiichi Pharmaceutical Co. Ltd, 1-16 Kita-kasai 1-Chome, Tokyo, Edogawa-ku, 134-8630, Japan.
Mori
T
T
Moriyama
S
S
Shibano
T
T
D000818:Animals; D003331:Coronary Vessels / Q000601:surgery; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism*; D004790:Enzyme Induction; D006333:Heart Failure / Q000201:enzymology*; D008026:Ligation; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D009638:Norepinephrine / Q000097:blood; D009929:Organ Size; D051381:Rats; D017207:Rats, Sprague-Dawley; D051552:beta-Adrenergic Receptor Kinases
D017868:Cyclic AMP-Dependent Protein Kinases; D051552:beta-Adrenergic Receptor Kinases; D009638:Norepinephrine